While hospitals in many parts of the world have faced unprecedented challenges with routine clinical services and had to suspend clinical trials, hospitals in Australia have not been as adversely affected with most maintaining clinical research activity.
The Peter MacCallum Cancer Centre (Peter Mac – www.petermac.org) is still adding patients to its CAR-T trials and continues to provide CAR-T treatments for approved indication, as part of the full spectrum of care for patients with cancer.
Cell Therapies Pty Ltd, the global contract manufacturing organisation that is affiliated with Peter Mac, has also remained fully functional during the past few months, with the ability to provide all our usual services. These include:
- TGA-approved GMP manufacturing for clinical trials and the commercial market
- Translation and process development
- Apheresis network management
- Manufacturing, quality, clinical and regulatory consulting
Please contact us at www.celltherapies.com.au/contact/ to get started.
